Neuroone Medical Stock Forward View
| NMTC Stock | USD 0.91 0.01 1.11% |
Neuroone Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Neuroone Medical stock prices and determine the direction of Neuroone Medical Technologies's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Neuroone Medical's historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time, The value of RSI of Neuroone Medical's share price is at 57. This indicates that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Neuroone Medical, making its price go up or down. Momentum 57
Buy Extended
Oversold | Overbought |
Using Neuroone Medical hype-based prediction, you can estimate the value of Neuroone Medical Technologies from the perspective of Neuroone Medical response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Neuroone Medical Technologies on the next trading day is expected to be 0.86 with a mean absolute deviation of 0.03 and the sum of the absolute errors of 1.74. Neuroone Medical after-hype prediction price | USD 0.91 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Neuroone Medical to cross-verify your projections. Neuroone Medical Additional Predictive Modules
Most predictive techniques to examine Neuroone price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Neuroone using various technical indicators. When you analyze Neuroone charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Neuroone Medical Naive Prediction Price Forecast For the 30th of January
Given 90 days horizon, the Naive Prediction forecasted value of Neuroone Medical Technologies on the next trading day is expected to be 0.86 with a mean absolute deviation of 0.03, mean absolute percentage error of 0, and the sum of the absolute errors of 1.74.Please note that although there have been many attempts to predict Neuroone Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Neuroone Medical's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Neuroone Medical Stock Forecast Pattern
| Backtest Neuroone Medical | Neuroone Medical Price Prediction | Buy or Sell Advice |
Neuroone Medical Forecasted Value
In the context of forecasting Neuroone Medical's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Neuroone Medical's downside and upside margins for the forecasting period are 0.01 and 5.85, respectively. We have considered Neuroone Medical's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Neuroone Medical stock data series using in forecasting. Note that when a statistical model is used to represent Neuroone Medical stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 111.5446 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0286 |
| MAPE | Mean absolute percentage error | 0.0388 |
| SAE | Sum of the absolute errors | 1.7439 |
Predictive Modules for Neuroone Medical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Neuroone Medical Tec. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Neuroone Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Neuroone Medical After-Hype Price Density Analysis
As far as predicting the price of Neuroone Medical at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Neuroone Medical or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Neuroone Medical, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Neuroone Medical Estimiated After-Hype Price Volatility
In the context of predicting Neuroone Medical's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Neuroone Medical's historical news coverage. Neuroone Medical's after-hype downside and upside margins for the prediction period are 0.05 and 5.90, respectively. We have considered Neuroone Medical's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Neuroone Medical is abnormally volatile at this time. Analysis and calculation of next after-hype price of Neuroone Medical Tec is based on 3 months time horizon.
Neuroone Medical Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Neuroone Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Neuroone Medical backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Neuroone Medical, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.35 | 4.99 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.91 | 0.91 | 0.00 |
|
Neuroone Medical Hype Timeline
Neuroone Medical Tec is now traded for 0.91. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Neuroone is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is now at 0.35%. %. The volatility of related hype on Neuroone Medical is about 0.0%, with the expected price after the next announcement by competition of 0.91. About 35.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.16. Neuroone Medical Tec had not issued any dividends in recent years. The entity had 1:3 split on the 1st of April 2021. Given the investment horizon of 90 days the next anticipated press release will be uncertain. Check out Historical Fundamental Analysis of Neuroone Medical to cross-verify your projections.Neuroone Medical Related Hype Analysis
Having access to credible news sources related to Neuroone Medical's direct competition is more important than ever and may enhance your ability to predict Neuroone Medical's future price movements. Getting to know how Neuroone Medical's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Neuroone Medical may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ECOR | Electrocore LLC | 0.00 | 0 per month | 3.63 | 0.12 | 10.17 | (6.07) | 31.20 | |
| MYO | Myomo Inc | 0.00 | 0 per month | 0.00 | (0.02) | 8.79 | (7.61) | 21.89 | |
| YI | 111 Inc | 0.00 | 0 per month | 4.33 | 0.06 | 8.07 | (8.04) | 47.07 | |
| HYPD | Hyperion DeFi | 0.00 | 0 per month | 0.00 | (0.08) | 13.58 | (11.49) | 34.90 | |
| STRR | Star Equity Holdings | 0.00 | 0 per month | 0.00 | (0.05) | 3.21 | (4.79) | 12.75 | |
| ATHE | Alterity Therapeutics | 0.00 | 0 per month | 0.00 | (0.10) | 5.71 | (7.44) | 17.55 | |
| BDMD | Baird Medical Investment | 0.00 | 0 per month | 0.00 | (0.06) | 8.67 | (8.00) | 26.61 | |
| ZYXI | Zynex Inc | 0.00 | 0 per month | 0.00 | (0.1) | 29.17 | (31.58) | 163.35 | |
| CTSO | Cytosorbents Crp | 0.00 | 0 per month | 0.00 | (0.04) | 7.58 | (7.41) | 29.40 | |
| RBOT | Vicarious Surgical | 0.00 | 0 per month | 0.00 | (0.19) | 11.90 | (9.09) | 36.01 |
Other Forecasting Options for Neuroone Medical
For every potential investor in Neuroone, whether a beginner or expert, Neuroone Medical's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Neuroone Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Neuroone. Basic forecasting techniques help filter out the noise by identifying Neuroone Medical's price trends.Neuroone Medical Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Neuroone Medical stock to make a market-neutral strategy. Peer analysis of Neuroone Medical could also be used in its relative valuation, which is a method of valuing Neuroone Medical by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Neuroone Medical Market Strength Events
Market strength indicators help investors to evaluate how Neuroone Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Neuroone Medical shares will generate the highest return on investment. By undertsting and applying Neuroone Medical stock market strength indicators, traders can identify Neuroone Medical Technologies entry and exit signals to maximize returns.
Neuroone Medical Risk Indicators
The analysis of Neuroone Medical's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Neuroone Medical's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting neuroone stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.72 | |||
| Semi Deviation | 3.87 | |||
| Standard Deviation | 4.99 | |||
| Variance | 24.93 | |||
| Downside Variance | 20.62 | |||
| Semi Variance | 14.96 | |||
| Expected Short fall | (4.89) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Neuroone Medical
The number of cover stories for Neuroone Medical depends on current market conditions and Neuroone Medical's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Neuroone Medical is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Neuroone Medical's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Neuroone Medical Short Properties
Neuroone Medical's future price predictability will typically decrease when Neuroone Medical's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Neuroone Medical Technologies often depends not only on the future outlook of the potential Neuroone Medical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Neuroone Medical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 40.2 M | |
| Cash And Short Term Investments | 6.6 M |
Check out Historical Fundamental Analysis of Neuroone Medical to cross-verify your projections. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Will Stock sector continue expanding? Could Neuroone diversify its offerings? Factors like these will boost the valuation of Neuroone Medical. Anticipated expansion of Neuroone directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Neuroone Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of Neuroone Medical Tec is measured differently than its book value, which is the value of Neuroone that is recorded on the company's balance sheet. Investors also form their own opinion of Neuroone Medical's value that differs from its market value or its book value, called intrinsic value, which is Neuroone Medical's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Neuroone Medical's market value can be influenced by many factors that don't directly affect Neuroone Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Neuroone Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Neuroone Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Neuroone Medical's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.